| # | Drug | Count |
|---|---|---|
| 0 | ATAZANAVIR | 51 |
| 1 | RITONAVIR | 42 |
| 2 | FUROSEMIDE | 40 |
| 3 | METHOTREXATE SODIUM | 30 |
| 4 | LAMIVUDINE | 29 |
| 5 | RIBAVIRIN | 25 |
| 6 | RITONAVIR 100 MG | 25 |
| 7 | CYCLOSPORINE | 24 |
| 8 | METHOTREXATE | 24 |
| 9 | LAMIVUDINE ORAL | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATAZANAVIR AND COBICISTAT | 3 | 0.0122 |
| 1 | DIFLUNISAL | 3 | 0.0037 |
| 2 | ATAZANAVIR | 51 | 0.0036 |
| 3 | OMADACYCLINE | 4 | 0.0023 |
| 4 | ONASEMNOGENE ABEPARVOVEC-XIOI | 5 | 0.0022 |
| 5 | TECLISTAMAB-CQYV | 4 | 0.0017 |
| 6 | RITONAVIR 100 MG | 25 | 0.0017 |
| 7 | LAMIVUDINE | 29 | 0.0011 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 9 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 10 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 1 | Complement Factor D Inhibitor [EPC] | 1 | 0.0032 |
| 2 | Antileishmanial [EPC] | 1 | 0.0026 |
| 3 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 4 | Selectin Blocker [EPC] | 2 | 0.0014 |
| 5 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 6 | Protease Inhibitor [EPC] | 47 | 0.0011 |
| 7 | Thyroid Hormone Receptor beta Agonist [EPC] | 2 | 0.0009 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 50 | 0.0008 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 37 | 0.0008 |